tripitramine has been researched along with himbacine in 2 studies
| Studies (tripitramine) | Trials (tripitramine) | Recent Studies (post-2010) (tripitramine) | Studies (himbacine) | Trials (himbacine) | Recent Studies (post-2010) (himbacine) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 73 | 0 | 9 |
| Protein | Taxonomy | tripitramine (IC50) | himbacine (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0175 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.1144 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 1.016 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.5482 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.3336 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhme, TM; Dannhardt, G; Keim, C; Lambrecht, G; Mutschler, E | 1 |
| Potter, LT; Purkerson, SL | 1 |
2 other study(ies) available for tripitramine and himbacine
| Article | Year |
|---|---|
Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.
Topics: Alzheimer Disease; Humans; In Vitro Techniques; Ligands; Quinuclidines; Radiopharmaceuticals; Receptor, Muscarinic M2; Receptors, Muscarinic; Tomography, Emission-Computed | 2001 |
Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors.
Topics: Alkaloids; Animals; Benzodiazepines; Binding, Competitive; Cats; CHO Cells; Corpus Striatum; Cricetinae; Elapid Venoms; Furans; Gallamine Triethiodide; Humans; Male; Muscarinic Antagonists; N-Methylscopolamine; Naphthalenes; Neurotoxins; Piperidines; Pirenzepine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Receptors, Muscarinic; Recombinant Proteins | 1998 |